Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
Paul B RizzoliDepartment of Neurology, Brigham and Women's Faulkner Hospital, John R. Graham Headache Center, Boston, MA, USAAbstract: The serotonin receptor agonist triptan drugs (5-HT1B/1D receptor agonists) have been in use for over 20 years in the abortive management of migraine. Althou...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-03-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Online Access: | http://www.dovepress.com/emerging-therapeutic-options-for-acute-migraine-focus-on-the-potential-a16290 |